Changed date for BioGaia's Year-end report
Latest press releases from BioGaia:
2009-12-08 BioGaia nominates two Executive Vice Presidents
2009-10-22 Interim report 1 January - 30 September 2009
2009-10-08 BioGaia agreement for Denmark
For additional information contact:
Peter Rothschild, President, telephone: +46 8 -555 293 00
Jan Annwall, Executive Vice President, telephone: +46 8-555 293 00
BioGaia is a biotechnology company that develops, markets and sells probiotic products
with documented health benefits. The products are primarily based on the lactic acid
bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects.
The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list
of the NASDAQ OMX Nordic Exchange Stockholm.
www.biogaia.com